@xconomy.com 7 months ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com 8 months ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com 1 year ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com 2 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?